Acurx Pharmaceuticals, Inc.
ACXP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,993 | -$2,246 | -$2,149 | -$2,782 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $410 | $444 | $538 |
| Change in WC | -$228 | $165 | -$346 | -$7 |
| Other Non-Cash | $340 | $0 | $0 | $0 |
| Operating Cash Flow | -$1,881 | -$1,671 | -$2,051 | -$2,250 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,725 | $610 | $2,989 | $195 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | $2,481 | $0 | $0 |
| Financing Cash Flow | $1,724 | $3,091 | $2,989 | $195 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$157 | $1,420 | $937 | -$2,056 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,064 | $4,644 | $3,707 | $5,763 |
| End Cash | $5,907 | $6,064 | $4,644 | $3,707 |
| Free Cash Flow | -$1,881 | -$1,671 | -$2,051 | -$2,250 |